Combating HIV/AIDS: biomedical approaches towards prevention

For over three decades, HIV/AIDS has had a deleterious impact on public health the world over. There is still no cure for the disease although preventive strategies have evolved over the years to reduce its impact. In addition to behavioural change approaches, biomedical interventions have played a major part in reduction of HIV transmission and subsequently the burden associated with the HIV/AIDS disease. Early biomedical approaches include physical barriers such as condoms, use of clean injection equipment for intravenous drug users, blood and blood product screening. More recently, medical male circumcision and use of anti-retroviral drugs for prevention have been introduced. While these interventions have had a fundamental impact in reducing HIV incidence, the burden in many populations remains. Therefore, there is need to develop new biomedical methods to augment existing efforts. Future biomedical approaches may for instance include use of compounds that modulate the body’s immune system, such as acetylsalicylic acid, to cause resistance to HIV infection. Such approaches could be added to the HIV prevention toolkit.Keywords: HIV/AIDS, biomedical, prevention, immune quiescenceAfr. J. Biomed. Res. Vol. 22 (May, 2019); 105- 11

Antimicrobial efficacy of Hibiscus Fuscus garcke aqueous and ethanol extracts on tooth root canal microorganisms

Objective: To determine the antimicrobial efficacy of Hibiscus fucus extracts against six root canal microorganisms. Design: In-vitro analytical study. Setting: Department of Medical Microbiology, University of Nairobi. Material and Methods: Hibiscus fuscus twigs were collected, dried and ground into coarse powder which was macerated in sterile distilled water and 80% ethanol. The aqueous filtrates were lipolyzed, while the ethanol filtrates were reduced, and oven dried into powder. Tenfold liquid microdilution of 50 mg/ml Hibiscus fuscus extracts against pure strains of Enterococcus faecalis, Streptococcus mutans, Staphylococcus aureus, Fusobacterium nucleatum, Lactobacillus acidophilus and Candida albicans were incubated for 24 and 48 hours. Sodium hypochlorite 5.25% and 2% Chlorhexidine gluconate were the controls. Outcome measures: Percentage growth inhibition measured by changes in growth of microorganism cultures exposed to Hibiscus fuscus extracts. One-way analysis of variance and Tukey’s HSD test were used to test for any differences. Results: Fifty mg/ml Hibiscus fuscus aqueous extracts attained 122.01% ± 22.89, at 95% CI [108.79, 135] and (105.73% ± 7.64, at 95% CI [101.32,110.14] growth inhibition against Enterococcus faecalis and Fusobacterium nucleatum for 24 hours incubation similar to those obtained with 5.25% Sodium hypochlorite, and 2% Chlorhexidine gluconate at p=0.899947 (Tukey’s HSD). Other bacteria tested and Candida albicans showed resistance Conclusion: Fifty mg/ml Hibiscus fuscus aqueous extract showed bactericidal efficacy against E. faecalis (ATCC® 29212 ™), and F. nucleatum (ATCC® 25586™) comparable to 5.25% Sodium hypochlorite and 2% Chlorhexidine gluconate. Investigation to test pure Hibiscus fuscus extracts as a potential source of root canal irrigant is needed